Composition and method for treatment of macular degeneration

Details Composition and method for treatment of macular degeneration Composition and method for treatment of macular degeneration

1989-04-20

1991-12-24

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Heavy metal or compound thereof

424630, 424639, 424641, 514251, 514345, 514458, 514474, 514562, 514912, A61K 3324, A61K 3334, A61K 3332, A61K 31525, A61K 3144, A61K 31355, A61K 3134, A61K 31195

Patent

active

050751166

ABSTRACT:
In accordance with the present invention, a composition is provided with Vitamins C and E, zinc, copper, selenium, manganese, and at least one of L-cysteine, pyridoxine, and riboflavin. The Vitamins C and E serve as antioxidants, while the zinc, copper, selenium and manganese serve as cofactors for metalloenzymes which scavenge oxidizers. The remaining three elements tend to enhance glutathione concentration. All the elements are provided in a tablet or caplet form which is suitable for oral ingestion. Preferably, the composition is taken periodically each day of a treatment period.

REFERENCES:
patent: 4002758 (1977-01-01), Bigou
Lawrence J. Machlin; "Free Radical Tissue Damage: Protective Role of Antioxidant Nutrients"; Clinical Nutrition, Hoffman-LaRoche Inc., Nutley, NJ 07110, U.S.A., FASEB 08926638/87/0001-0441; pp. 441-445.

Affiliated with

Also associated with

Rating

Composition and method for treatment of macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method for treatment of macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treatment of macular degeneration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-42416